AstaReal, Inc. (Burlington, NJ) reported its new Canadian Product License approval for astaxanthin.

Approving up to 12 mg per day, AstaReal, Inc. received notification from Health Canada approving the use of AstaReal natural astaxanthin as a “source of antioxidants” and to “help improve muscle endurance.”

Charles DePrince, president and CEO, AstaReal, said the approval is an exciting testament to the company’s dedication and continued research of natural astaxanthin. “With more than a hundred published studies involving AstaReal astaxanthin under our belt, AstaReal’s research program shows no sign of slowing,” said DePrince.

AstaReal, Inc. is a biotech company within the Fuji Group exclusively dedicated to the production, research and marketing of natural astaxanthin.

For more information, visit www.fujihealthscience.com.